|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/06 | |
| A61K 38/07 | |||
| A61P 9/00 | |||
| A61P 9/10 |
| (11) | Patento numeris | 2908839 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13849406.7 |
| Europos patento paraiškos padavimo data | 2013-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/066228 |
| Data | 2013-10-22 |
| (87) | Numeris | WO 2014/066419 |
| Data | 2014-05-01 |
| (30) | Numeris | Data | Šalis |
| 201261716867 P | 2012-10-22 | US | |
| 201361822752 P | 2013-05-13 | US | |
| 201361839743 P | 2013-06-26 | US | |
| 201361839750 P | 2013-06-26 | US |
| (72) |
WILSON, D. Travis, US
SABBAH, Hani N., US
|
| (73) |
Stealth Peptides International, Inc.,
2nd Floor Le Prince de Galles 3-5 Avenue des Citronniers, 98000 Monte-Carlo,
MC
Henry Ford Health Systems, 2799 West Grand Boulevard, Detroit, MI 48202, US |
| (54) | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH |
| METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH |